# Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM)

> **NCT06239974** · NA · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 94 (estimated)

## Conditions studied

- Chest Pain

## Interventions

- **DRUG:** Vericiguat
- **DIAGNOSTIC_TEST:** Stress Cardiac Magnetic Resonance

## Key facts

- **NCT ID:** NCT06239974
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06239974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06239974, "Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06239974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*